Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Annual Bibliography of Significant Advances in Dietary Supplement Research 2004
This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers; This is the first issue of the Bibliography to highlight research on phenolics and flavonoids.
- Annual Bibliography of Significant Advances in Dietary Supplement Research 2004
This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers; This is the first issue of the Bibliography to highlight research on phenolics and flavonoids.
- Annual Bibliography of Significant Advances in Dietary Supplement Research 2004
This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers; This is the first issue of the Bibliography to highlight research on phenolics and flavonoids.
- Euromed Completes New Saw Palmetto Berry Processing Plant
Company announces the successful completion of construction of a new saw palmetto berry processing plant in Central Florida in time for processing this year's Saw Palmetto crop.
- Euromed Completes New Saw Palmetto Berry Processing Plant
Company announces the successful completion of construction of a new saw palmetto berry processing plant in Central Florida in time for processing this year's Saw Palmetto crop.
- Euromed Completes New Saw Palmetto Berry Processing Plant
Company announces the successful completion of construction of a new saw palmetto berry processing plant in Central Florida in time for processing this year's Saw Palmetto crop.
- AOAC Antioxidant Methods Committee Meets At Supplyside West - Last Chance for Industry Input Into Methods for Polyphenol Measurements
The AOAC antioxidant methods committee is currently at the final step of submitting the methods of choice for total polyphenol measurements to the AOAC for lab validation and eventually publication. The meeting at SupplySide is the last chance prior to submission that industry will have a chance to provide input - Nov 9th at the Sands Expo from 3:00-4:30pm, Room 4001B.
- AOAC Antioxidant Methods Committee Meets At Supplyside West - Last Chance for Industry Input Into Methods for Polyphenol Measurements
The AOAC antioxidant methods committee is currently at the final step of submitting the methods of choice for total polyphenol measurements to the AOAC for lab validation and eventually publication. The meeting at SupplySide is the last chance prior to submission that industry will have a chance to provide input - Nov 9th at the Sands Expo from 3:00-4:30pm, Room 4001B.
- AOAC Antioxidant Methods Committee Meets At Supplyside West - Last Chance for Industry Input Into Methods for Polyphenol Measurements
The AOAC antioxidant methods committee is currently at the final step of submitting the methods of choice for total polyphenol measurements to the AOAC for lab validation and eventually publication. The meeting at SupplySide is the last chance prior to submission that industry will have a chance to provide input - Nov 9th at the Sands Expo from 3:00-4:30pm, Room 4001B.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Herbalife Launches New Heart Health Product Line with Neptune Krill Oil and Plant Sterols
Neptune Technologies & Bioressources Inc.
(NTB: TSX-V), is pleased to announce that Herbalife International (HLF: NYSE), has launched a comprehensive heart health product portfolio with “CORE-COMPLEX PACK” and “TRISHEILD™”, featuring Neptune Krill Oil (NKO®) as the main ingredient.
- Planet Organic Health Corp Announces Annual Results
Planet Organic Health Corp Announces Annual Results Company posts record profitability. Net income increase of 140.4%
- Planet Organic Health Corp Announces Annual Results
Planet Organic Health Corp Announces Annual Results Company posts record profitability. Net income increase of 140.4%
- Planet Organic Health Corp Announces Annual Results
Planet Organic Health Corp Announces Annual Results Company posts record profitability. Net income increase of 140.4%
- Planet Organic Health Corp Announces Annual Results
Planet Organic Health Corp Announces Annual Results Company posts record profitability. Net income increase of 140.4%
- Planet Organic Health Corp Announces Annual Results
Planet Organic Health Corp Announces Annual Results Company posts record profitability. Net income increase of 140.4%
- Gee Lawson to Distribute OptiMSM® in Europe
Cardinal Nutrition, announced that effective November 1, Gee Lawson Nutritional will represent sales of its OptiMSM® across Europe.
- Gee Lawson to Distribute OptiMSM® in Europe
Cardinal Nutrition, announced that effective November 1, Gee Lawson Nutritional will represent sales of its OptiMSM® across Europe.
- Gee Lawson to Distribute OptiMSM® in Europe
Cardinal Nutrition, announced that effective November 1, Gee Lawson Nutritional will represent sales of its OptiMSM® across Europe.
- Gee Lawson to Distribute OptiMSM® in Europe
Cardinal Nutrition, announced that effective November 1, Gee Lawson Nutritional will represent sales of its OptiMSM® across Europe.
- Gee Lawson to Distribute OptiMSM® in Europe
Cardinal Nutrition, announced that effective November 1, Gee Lawson Nutritional will represent sales of its OptiMSM® across Europe.
- Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy
New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7).
- Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy
New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7).
- Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy
New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7).
- Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy
New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7).
- Study Examines the Safe Consumption Of Soy Isoflavones As Hormone Replacement Therapy
New results, based on studies of an experimental model designed to investigate consumption of soy-derived products as a natural alternative to hormone replacement therapy in post-menopausal breast cancer women, were presented today at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; results indicate that consumption of Soyselect® does not stimulate the growth of breast cancer tumors in the experimental model used (xenograft MCF-7).
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- Nutracon China - December 3-4, 2005
Industry leaders are invited to attend Nutracon China 2005, joining New Hope Natural media, the State Food & Drug Administration (SFDA) of China and other significant industry members – from around the globe - at this unique, market-relevant event.
- Nutracon China - December 3-4, 2005
Industry leaders are invited to attend Nutracon China 2005, joining New Hope Natural media, the State Food & Drug Administration (SFDA) of China and other significant industry members – from around the globe - at this unique, market-relevant event.
- Nutracon China - December 3-4, 2005
Industry leaders are invited to attend Nutracon China 2005, joining New Hope Natural media, the State Food & Drug Administration (SFDA) of China and other significant industry members – from around the globe - at this unique, market-relevant event.
- Nutracon China - December 3-4, 2005
Industry leaders are invited to attend Nutracon China 2005, joining New Hope Natural media, the State Food & Drug Administration (SFDA) of China and other significant industry members – from around the globe - at this unique, market-relevant event.
- Nutracon China - December 3-4, 2005
Industry leaders are invited to attend Nutracon China 2005, joining New Hope Natural media, the State Food & Drug Administration (SFDA) of China and other significant industry members – from around the globe - at this unique, market-relevant event.
- Healthy Talk Radio with Deborah Ray to expand to Sirius Satellite Radio
Beginning on November 14, 2005, Healthy Talk Radio with Deborah Ray will begin broadcasting live on LIME, “Healthy Living with a Twist”, over the Sirius Satellite Radio Network, a nationally syndicated integrative health, news and lifestyle radio program will air Monday through Friday, 11:00 a.m. to 12 Noon, and on Sundays, 5:00 p.m. to 7:00 p.m., eastern time on Sirius channel 114.
- Healthy Talk Radio with Deborah Ray to expand to Sirius Satellite Radio
Beginning on November 14, 2005, Healthy Talk Radio with Deborah Ray will begin broadcasting live on LIME, “Healthy Living with a Twist”, over the Sirius Satellite Radio Network, a nationally syndicated integrative health, news and lifestyle radio program will air Monday through Friday, 11:00 a.m. to 12 Noon, and on Sundays, 5:00 p.m. to 7:00 p.m., eastern time on Sirius channel 114.
- Healthy Talk Radio with Deborah Ray to expand to Sirius Satellite Radio
Beginning on November 14, 2005, Healthy Talk Radio with Deborah Ray will begin broadcasting live on LIME, “Healthy Living with a Twist”, over the Sirius Satellite Radio Network, a nationally syndicated integrative health, news and lifestyle radio program will air Monday through Friday, 11:00 a.m. to 12 Noon, and on Sundays, 5:00 p.m. to 7:00 p.m., eastern time on Sirius channel 114.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- Zuellig Group Nutrition and Ingredients (ZGNI) Appoints Bill Murphy General Manager
Company announces appointment of Bill Murphy to general manager of the Zuellig Functional Food Ingredients (ZFFI) business unit, to lead ZGNI's entry into the premix and food ingredients market.
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health
Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Industry Coalition Advises Against Use of Dietary Supplements as Remedy for Avian Flu
The trade associations of the dietary supplement industry urge industry to refuse to stock or sell any products that are presented as preventing, treating or curing avian flu, refrain from promoting any dietary supplement as a preventative, cure or treatment for avian flu, and arge those who believe they may have avian flu or may have come in contact with it should immediately contact a healthcare professional.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
PURCHASE, NY, November 4, 2005 -- Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced the resignation of Gail Montgomery as a director and officer of the Company. Ms. Montgomery had served as President, CEO and a director since September 2000.
The Company also announced that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer, and that the Board is considering Mr. Intlekofer and other candidates for election as CEO. Previously Mr. Intlekofer served as Senior Vice President-Corporate Development and Chief Financial Officer.
John Gutfreund, Chairman of the Board, said “We appreciate Gail’s enthusiasm and leadership in developing a solid scientific foundation for the company during her tenure.”
About Nutrition 21
Nutrition 21 is a nutritional biosciences company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The Company markets Chromax® chromium picolinate, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome®, which is available through diabetes educators or at www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at http://www.nutrition21.com. http://www.chromax.com and http://www.diachrome.com
# # #
Contact:
Paul Intlekofer, 914-701-4507
|